Home
Search Center
Journal List
CMA
Contact US
|
Chinese
You Position:
Home
> Paper
Application of bilateral supraclavicular artery island flaps in the repair of hypopharyngeal and cervical skin defects: a case report
( views:0, downloads:0 )
Author:
No author available
Journal Title:
Chinese Medical Journal
Issue:
11
DOI:
10.1097/CM9.0000000000000831
Key Word:
No keyword available
Abstract: No abstract available
Reference
[1]Zhijian Tang,Xiaohong Chang,XUE Ye,etc.
Usefulness of human epididymis protein 4 in predicting cytoreductive surgical outcomes for advanced ovarian tubal and peritoneal carcinoma
[J].2015,(3).
[2]Marijn M, Speeckaert,Reinhart, Speeckaert,Joris R, Delanghe.
Human epididymis protein 4 in cancer diagnostics: a promising and reliable tumor marker.
[J].2013,59.
[3]Simona Ferraro,Domitilla Schiumarini,Mauro Panteghini.
Human epididymis protein 4: Factors of variation
[J].2015,438.
[4]Diamandis EP.
Cancer biomarkers: can we turn recent failures into success?
[J].2010,102(19).
[5]Vincent,Dochez,Hélène,Caillon,Edouard,Vaucel,etc.
Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review.
[J].2019,12(1).
[6].
Serum levels of the ovarian cancer biomarker HE4 are decreased in pregnancy and increase with age
[J].2012,206(4).
[7]Huang, Jinbing,Chen, Junying,Huang, Qiaoqiao.
Diagnostic value of HE4 in ovarian cancer: A meta-analysis
[J].2018,231.
[8]Siegel, Rebecca L.,Miller, Kimberly D.,Jemal, Ahmedin.
Cancer statistics, 2019
[J].2019,69(1).
[9]Sandri,M.T.,Bottari,F.,Franchi,D.,etc.
Comparison of HE4, CA125 and ROMA algorithm in women with a pelvic mass: Correlation with pathological outcome
[J].2013,128(2).
[10]Simona Ferraro,Mauro Panteghini.
Making new biomarkers a reality: the case of serum human epididymis protein 4
[J].2019,57(9).
[11]Sarikapan, Wilailak,Karen K L, Chan,Chi An, Chen,etc.
Distinguishing benign from malignant pelvic mass utilizing an algorithm with HE4, menopausal status, and ultrasound findings.
[J].2015,26.
[12]Nguyen Vu Quoc,Huy,Vo,Van Khoa,Le Minh,Tam,etc.
Standard and optimal cut-off values of serum ca-125, HE4 and ROMA in preoperative prediction of ovarian cancer in Vietnam.
[J].2018,25.
[13]Scaletta, Giuseppe,Plotti, Francesco,Luvero, Daniela,etc.
The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review
[J].2017,17(7/12).
[14]Vincent,Dochez,Mélanie,Randet,Céline,Renaudeau,etc.
Efficacy of HE4, CA125, Risk of Malignancy Index and Risk of Ovarian Malignancy Index to Detect Ovarian Cancer in Women with Presumed Benign Ovarian Tumours: A Prospective, Multicentre Trial.
[J].2019,8(11).
[15]Molina R,Pahisa J,Torne A,etc.
Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases.
[J].2011,57(11).
[16]Yanaranop, Marut,Anakrat, Vahcharapot,Siricharoenthai, Somchai,etc.
Is the Risk of Ovarian Malignancy Algorithm Better Than Other Tests for Predicting Ovarian Malignancy in Women with Pelvic Masses?
[J].2017,82(1).
[17]Simona Ferraro,Federica Braga,Monica Lanzoni.
Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis: a systematic review
[J].2013,66(4).
[18]Yu, Shinae,Lee, Jin Kyung,Kim, Jea-Hoon,etc.
Diagnostic performance and establishment of reference limits of HE4 in Korean healthy women
[J].2016,143(1).
[19]Chang X,Liao Q,Cui H,etc.
Human epididymis protein 4 (HE4) as a serum tumor biomarker in patients with ovarian carcinoma.
[J].2011,21(5).
[20]Nm, Mokhtar,M, Thevarajah,Noorazmi, Ma,etc.
Human epididymis protein 4 reference intervals in a multiethnic asian women population.
[J].2012,13.
[21]Jong Ho, Moon,Hyo Jin, Lee,Woo Dae, Kang,etc.
Prognostic value of serum CA-125 in patients with advanced epithelial ovarian cancer followed by complete remission after adjuvant chemotherapy.
[J].2013,56.
[22]Macedo,A.C.L.,DaRosa,M.I.,Lumertz,S.,etc.
Accuracy of serum human epididymis protein 4 in ovarian cancer diagnosis: A systematic review and meta-analysis
[J].2014,24(7).
[23]Alessia Aloisi,Patrizio Damiani,Pierluigi Benedetti-Panici,etc.
Does HE4 have a role as biomarker in the recurrence of ovarian cancer?
[J].2012,33(6).
[24]Qin,J.,Lin,J.,Sangvatanakul,V..
Human epididymis protein 4 for differential diagnosis between benign gynecologic disease and ovarian cancer: A systematic review and meta-analysis
[J].2013,167(1).
[25]Yaping, Tian,Chuanxin, Wang,Liming, Cheng,etc.
Determination of reference intervals of serum levels of human epididymis protein 4 (HE4) in Chinese women.
[J].2015,8.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData
|
Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:
yiyao@wanfangdata.com.cn